Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.

McClung HM, Thomas SL, Osenkowski P, Toth M, Menon P, Raz A, Fridman R, Rempel SA.

Neurosci Lett. 2007 May 29;419(2):172-7. Epub 2007 Apr 21.

2.

Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.

Infante JR, Matsubayashi H, Sato N, Tonascia J, Klein AP, Riall TA, Yeo C, Iacobuzio-Donahue C, Goggins M.

J Clin Oncol. 2007 Jan 20;25(3):319-25.

PMID:
17235047
3.

Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis.

Nozawa H, Chiu C, Hanahan D.

Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12493-8. Epub 2006 Aug 4.

4.

Pericellular proteases in angiogenesis and vasculogenesis.

van Hinsbergh VW, Engelse MA, Quax PH.

Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):716-28. Epub 2006 Feb 9. Review.

5.

Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination.

Deryugina EI, Zijlstra A, Partridge JJ, Kupriyanova TA, Madsen MA, Papagiannakopoulos T, Quigley JP.

Cancer Res. 2005 Dec 1;65(23):10959-69.

6.

Local proteolytic activity in tumor cell invasion and metastasis.

Ludwig T.

Bioessays. 2005 Nov;27(11):1181-91. Review.

PMID:
16237672
7.

Osteonectin influences growth and invasion of pancreatic cancer cells.

Guweidhi A, Kleeff J, Adwan H, Giese NA, Wente MN, Giese T, B├╝chler MW, Berger MR, Friess H.

Ann Surg. 2005 Aug;242(2):224-34.

8.

Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells.

Chen X, Su Y, Fingleton B, Acuff H, Matrisian LM, Zent R, Pozzi A.

Int J Cancer. 2005 Aug 10;116(1):52-61.

9.

Tumor-associated macrophages: the double-edged sword in cancer progression.

Chen JJ, Lin YC, Yao PL, Yuan A, Chen HY, Shun CT, Tsai MF, Chen CH, Yang PC.

J Clin Oncol. 2005 Feb 10;23(5):953-64. Epub 2004 Dec 14.

PMID:
15598976
10.

Microenvironmental and cellular consequences of altered blood flow in tumours.

Raghunand N, Gatenby RA, Gillies RJ.

Br J Radiol. 2003;76 Spec No 1:S11-22. Review.

PMID:
15456710
11.

SPARC and tumor growth: where the seed meets the soil?

Framson PE, Sage EH.

J Cell Biochem. 2004 Jul 1;92(4):679-90. Review.

PMID:
15211566
12.

Functional analysis of the matricellular protein SPARC with novel monoclonal antibodies.

Sweetwyne MT, Brekken RA, Workman G, Bradshaw AD, Carbon J, Siadak AW, Murri C, Sage EH.

J Histochem Cytochem. 2004 Jun;52(6):723-33.

PMID:
15150281
13.
14.

Pancreatic cancer.

Li D, Xie K, Wolff R, Abbruzzese JL.

Lancet. 2004 Mar 27;363(9414):1049-57. Review.

PMID:
15051286
15.

Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment.

Chantrain CF, Shimada H, Jodele S, Groshen S, Ye W, Shalinsky DR, Werb Z, Coussens LM, DeClerck YA.

Cancer Res. 2004 Mar 1;64(5):1675-86.

16.

Axis of evil: molecular mechanisms of cancer metastasis.

Bogenrieder T, Herlyn M.

Oncogene. 2003 Sep 29;22(42):6524-36. Review.

PMID:
14528277
17.

Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.

Koukourakis MI, Giatromanolaki A, Brekken RA, Sivridis E, Gatter KC, Harris AL, Sage EH.

Cancer Res. 2003 Sep 1;63(17):5376-80.

18.

SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.

Sato N, Fukushima N, Maehara N, Matsubayashi H, Koopmann J, Su GH, Hruban RH, Goggins M.

Oncogene. 2003 Aug 7;22(32):5021-30.

PMID:
12902985
19.

Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis.

Sage EH, Reed M, Funk SE, Truong T, Steadele M, Puolakkainen P, Maurice DH, Bassuk JA.

J Biol Chem. 2003 Sep 26;278(39):37849-57. Epub 2003 Jul 16.

20.

Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin.

Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A, Kalluri R.

Cancer Cell. 2003 Jun;3(6):589-601.

Supplemental Content

Support Center